The most important financial indicators for the company Drug Zoo Srl - Unique Identification Number 18514675:
sales in 2023 was
11.022
euro, registering a net profit of
5.124
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati in ferme mixte (cultura vegetala combinata cu cresterea animalelor) having the NACE code 150.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -75.0%, from 44.232 euro in the year 2022, to 11.022 euro in 2023.
The Net Profit increased by 3.132 euro, from 1.998 euro in 2022, to 5.124 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Drug Zoo Srl - CUI 18514675
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
140.022
124.559
161.670
89.400
77.302
65.605
66.673
85.572
56.307
59.714
Current Assets
89.677
91.996
96.110
138.269
169.653
190.720
180.128
109.713
128.224
133.507
Inventories
54.563
51.808
32.140
43.445
33.319
35.792
32.056
31.918
30.617
41.578
Receivables
34.792
39.601
50.985
85.647
129.264
147.396
143.098
77.710
91.612
82.990
Cash
322
588
12.984
9.176
7.070
7.533
4.974
84
5.995
8.939
Shareholders Funds
-19.528
-11.775
3.532
-16.346
-12.532
5.932
20.714
21.797
23.863
28.915
Social Capital
6.247
6.299
6.235
6.129
6.017
5.900
5.789
5.660
5.678
5.661
Debts
249.227
234.357
254.248
244.015
259.487
250.833
226.518
173.487
160.668
164.306
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"150 - 150"
CAEN Financial Year
150
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
133.507 euro in 2023 which includes Inventories of
41.578 euro, Receivables of
82.990 euro and cash availability of
8.939 euro.
The company's Equity was valued at
28.915 euro, while total Liabilities amounted to
164.306 euro.
Equity increased by 5.124 euro, from 23.863 euro in 2022, to 28.915 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Drug Zoo Srl